NCT02065479View on ClinicalTrials.gov

A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 22, 2019

Study Completion Date

April 22, 2019

Conditions
Coronary Artery Disease
Interventions
DRUG

Prasugrel

Comparison of platelet reactivity between prasugrel and ticagrelor

DRUG

Ticagrelor

Comparison of platelet reactivity between prasugrel and ticagrelor

Trial Locations (1)

32209

University of Florida, Jacksonville

All Listed Sponsors
lead

University of Florida

OTHER

NCT02065479 - A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function: | Biotech Hunter | Biotech Hunter